Sharpless Norman 4
4 · G1 Therapeutics, Inc. · Filed Aug 5, 2022
Insider Transaction Report
Form 4
Sharpless Norman
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-08-04+60,000→ 60,000 totalExercise: $10.49Exp: 2032-08-04→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in 36 equal monthly installments beginning August 31, 2022, subject to the Reporting Person's continued service through each applicable vesting date.